Literature DB >> 23632790

Platelet defects in congenital variant of Rett syndrome patients with FOXG1 mutations or reduced expression due to a position effect at 14q12.

Christophe Goubau1, Koen Devriendt, Nathalie Van der Aa, An Crepel, Dagmar Wieczorek, Tjitske Kleefstra, Marjolein H Willemsen, Anita Rauch, Andreas Tzschach, Thomy de Ravel, Peter Leemans, Chris Van Geet, Gunnar Buyse, Kathleen Freson.   

Abstract

The Forkhead box G1 (FOXG1) gene encodes a transcriptional repressor essential for early development of the telencephalon. Intragenic mutations and gene deletions leading to haploinsufficiency cause the congenital variant of Rett syndrome. We here describe Rett syndrome-like patients, three of them carrying a balanced translocation with breakpoint in the chromosome 14q12 region, and one patient having a 14q12 microdeletion excluding the FOXG1 gene. The hypothesis of long-range FOXG1-regulatory elements in this region was supported by our finding of reduced FOXG1 mRNA and protein levels in platelets and skin fibroblasts from these cases. Given that FOXG1 is not only expressed in brain but also in platelets, we have studied platelet morphology in these patients and two additional patients with FOXG1 mutations. Electron microscopy of their platelets showed some enlarged, rounder platelets with often abnormal alpha, and fewer dense granules. Platelet function studies were possible in one 14q12 translocation patient with a prolonged Ivy bleeding time and a patient with a heterozygous FOXG1 c.1248C>G mutation (p.Tyr416X). Both have a prolonged PFA-100 occlusion time with collagen and epinephrine and reduced aggregation responses to low dose of ADP and epinephrine. Dense granule ATP secretion was normal for strong agonists but absent for epinephrine. In conclusion, our study shows that by using platelets functional evidence of cis-regulatory elements in the 14q12 region result in reduced FOXG1 levels in patients' platelets having translocations or deletions in that region. These platelet functional abnormalities deserve further investigation regarding a non-transcriptional regulatory role for FOXG1 in these anucleated cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23632790      PMCID: PMC3831085          DOI: 10.1038/ejhg.2013.86

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  51 in total

1.  Foxg1 suppresses early cortical cell fate.

Authors:  Carina Hanashima; Suzanne C Li; Lijian Shen; Eseng Lai; Gord Fishell
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

2.  Questionable pathogenicity of FOXG1 duplication.

Authors:  David J Amor; Trent Burgess; Tiong Y Tan; Mark D Pertile
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

3.  The role of Foxg1 and dorsal midline signaling in the generation of Cajal-Retzius subtypes.

Authors:  Carina Hanashima; Marie Fernandes; Jean M Hebert; Gord Fishell
Journal:  J Neurosci       Date:  2007-10-10       Impact factor: 6.167

4.  14q12 and severe Rett-like phenotypes: new clinical insights and physical mapping of FOXG1-regulatory elements.

Authors:  Lila Allou; Laetitia Lambert; Daniel Amsallem; Eric Bieth; Patrick Edery; Anne Destrée; François Rivier; David Amor; Elizabeth Thompson; Julian Nicholl; Michael Harbord; Christophe Nemos; Aline Saunier; Aissa Moustaïne; Adeline Vigouroux; Philippe Jonveaux; Christophe Philippe
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

Review 5.  The proximal chromosome 14q microdeletion syndrome: delineation of the phenotype using high resolution SNP oligonucleotide microarray analysis (SOMA) and review of the literature.

Authors:  Edina Torgyekes; Alan L Shanske; Kwame Anyane-Yeboa; Odelia Nahum; Sara Pirzadeh; Einat Blumfield; Vaidehi Jobanputra; Dorothy Warburton; Brynn Levy
Journal:  Am J Med Genet A       Date:  2011-07-08       Impact factor: 2.802

6.  West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14.

Authors:  Jun Tohyama; Toshiyuki Yamamoto; Kana Hosoki; Keisuke Nagasaki; Noriyuki Akasaka; Tsukasa Ohashi; Yu Kobayashi; Shinji Saitoh
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

7.  Foxp3 regulates megakaryopoiesis and platelet function.

Authors:  Jamie J Bernard; Kathryn E Seweryniak; Anne D Koniski; Sherry L Spinelli; Neil Blumberg; Charles W Francis; Mark B Taubman; James Palis; Richard P Phipps
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

8.  Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1.

Authors:  Somasish Ghosh Dastidar; Farah H Bardai; Chi Ma; Valerie Price; Varun Rawat; Pragya Verma; Vinodh Narayanan; Santosh R D'Mello
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

9.  A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features.

Authors:  Filomena Tiziana Papa; Maria Antonietta Mencarelli; Rossella Caselli; Eleni Katzaki; Katia Sampieri; Ilaria Meloni; Francesca Ariani; Ilaria Longo; Angela Maggio; Paolo Balestri; Salvatore Grosso; Maria Angela Farnetani; Rosario Berardi; Francesca Mari; Alessandra Renieri
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

10.  The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.

Authors:  Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

View more
  5 in total

1.  Regulatory variants of FOXG1 in the context of its topological domain organisation.

Authors:  Mana M Mehrjouy; Ana Carolina S Fonseca; Nadja Ehmke; Giorgio Paskulin; Antonio Novelli; Francesco Benedicenti; Maria Antonietta Mencarelli; Alessandra Renieri; Tiffany Busa; Chantal Missirian; Claus Hansen; Kikue Terada Abe; Carlos Eduardo Speck-Martins; Angela M Vianna-Morgante; Mads Bak; Niels Tommerup
Journal:  Eur J Hum Genet       Date:  2017-12-30       Impact factor: 4.246

2.  Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin.

Authors:  Cinthya J Zepeda-Mendoza; Alexandra Bardon; Tammy Kammin; David J Harris; Helen Cox; Claire Redin; Zehra Ordulu; Michael E Talkowski; Cynthia C Morton
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

3.  RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome.

Authors:  Natasha L Pacheco; Michael R Heaven; Leanne M Holt; David K Crossman; Kristin J Boggio; Scott A Shaffer; Daniel L Flint; Michelle L Olsen
Journal:  Mol Autism       Date:  2017-10-24       Impact factor: 7.509

4.  Diagnosis of FOXG1 syndrome caused by recurrent balanced chromosomal rearrangements: case study and literature review.

Authors:  Connor P Craig; Emily Calamaro; Chin-To Fong; Anwar M Iqbal; Alexander R Paciorkowski; Bin Zhang
Journal:  Mol Cytogenet       Date:  2020-09-03       Impact factor: 2.009

5.  Platelet studies in autism spectrum disorder patients and first-degree relatives.

Authors:  Nora Bijl; Chantal Thys; Christine Wittevrongel; Wouter De la Marche; Koenraad Devriendt; Hilde Peeters; Chris Van Geet; Kathleen Freson
Journal:  Mol Autism       Date:  2015-10-23       Impact factor: 7.509

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.